Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel aldose reductase inhibitors (ARIs) targeting molecular pathways implicated in rare metabolic and diabetic complications. Its lead product, AT-007, addresses rare pediatric diseases like Galactosemia and SORD Deficiency by reducing toxic sugar metabolites. The company leverages advanced drug design, biomarker-driven development, and accelerated regulatory pathways to create selective therapies for underserved patient populations with high unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.